Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1269 results for "sun pharma"

For first time in 7 years, Pharma stocks lag Nifty50

Long-time favourites of Dalal Street, pharma stocks have underperformed equity benchmarks so far 2016 the first time in seven years. Shares of Sun Pharmaceuticals, India's most valuable pharma company, which was an outperformer for the last six ... Financial Express, 32 minutes ago

383 images for sun pharma

Financial Express, 3 days ago
Livemint.com, 1 week ago
Financial Express, 3 days ago
Indian Express, 3 hours ago
Financial Express, 1 day ago
Moneycontrol.com, 3 days ago
India Infoline, 2 weeks ago
PharmaVOICE, 2 weeks ago
Financial Express, 5 days ago
Business Standard India, 2 weeks ago

Aurobindo beats the pharma blues

Pharmaceutical tablets and capsules Even as larger peers Sun Pharmaceutical and Lupin faltered on the bourses despite strong June quarter (Q1) earnings, Aurobindo Pharma gained seven per cent on Wednesday. The company had declared its quarterly ...
 Business Standard India8 hours ago Aurobindo a bright spot in Indian pharma  Business Standard India10 hours ago

With an aim of expansion, pharma companies like Lupin and Torrent eyeing acquisition in overseas

MUMBAI: India's top pharmaceutical companies are set to embark on an acquisition spree to bulk up their overseas presence. Lupin, Torrent, Zydus Cadila, Intas, Aurobindo, Dr Reddy's and No. 1 Sun Pharma are said to be examining proposals of varying ...
 Economic Times4 hours ago
Sify

Sensex Ends 70 Points Higher Led By Gains In Infosys, HDFC Bank

Sensex and Nifty ended higher on Wednesday led by gains in drug maker Aurobindo Pharma which posted stellar June quarter numbers but sentiment remained edgy as investors awaited further clues on whether the Federal Reserve will raise U.S. interest ...
 NDTV Profit14 hours ago Sensex up marginally; Pharma stocks edge higher  Sify15 hours ago Sensex ends 70 points higher; investors remain wary ahead of Fed comments  Hindu Business Line14 hours ago Sensex up 80 points, set to end modestly higher  Sify13 hours ago
Money Control

Sensex, Nifty sluggish; Infy Sun Pharma up, InterGlobe slips

IndiGo Airlines owner InterGlobe Aviation fell 2 percent as media reports suggest that Tigerair may take back 11 jets subleased to IndiGo. Tigerair says it will grow capacity via the returning aircraft subleased to IndiGo.
 Money Control16 hours ago Sensex, Nifty continue to fall; Coal India, SBI most active  Money Control2 days ago Sensex breaks below 28K, down nearly 100 points; ICICI Bank, Sun Pharma top losers  Economic Times2 days ago Nifty hovers around 8650, Sensex weak; FMCG gains, auto falls  Money Control2 days ago
[x]  

Sensex, Nifty rangebound; Lupin, TCS, HUL major laggards

Lupin, TCS, HUL, Coal India and ITC are laggards while Maruti, NTPC, Cipla, Infosys and Sun Pharma are gainers in the Sensex.
 Money Control19 hours ago Sensex, Nifty fall for 2nd day; TCS, Lupin, NTPC shed 2%  Money Control2 days ago
Business Standard India

Nifty holds 8,600 amid choppy trades; IT shares gain

Markets have made a subdued opening tracking mixed trend among global peers along with weakness among capital goods and pharma leading the decline. However, the downside is limited due to buying demand among the IT space. By 9:35 am, the S&P BSE ...
 Smart Investor1 day ago Sensex hovers around 28,000; IT shares weigh  Smart Investor2 days ago Sensex hovers around 28,000; Tata group shares weak  Smart Investor18 hours ago Sensex hovers around 28,000, Midcaps fall; Infosys, TCS up 2%  Business Standard India1 day ago
Financial Express

BUZZ-Power Grid Corp of India hits record high ahead of earnings

India's Sun Pharma Q1 profit boosted by Gleevec generic MUMBAI, Aug 12 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic ...
 Reuters India1 week ago Sun Pharma Q1 net rises over 3-fold to Rs 2034 cr  Religare Securities1 week ago Sun Pharma Q1 profit soars three fold to 2,034 crore  Economic Times1 week ago Sun Pharma Q1 net jumps over three times  The Hindu1 week ago
[x]  
Money Control

Making Ranbaxy Units Compliant Time Consuming: Sun Pharma

New Delhi : Sun Pharma sees the remediationprocess at erstwhile Ranbaxy facilities as a "time consuming"process even as it aims to bring at least one of the plants toconform to current good manufacturing practice regulations(cGMP) in the current ...
 NDTV3 days ago To make Ranbaxy units cGMP compliant takes time  Press Trust of India3 days ago Making Ranbaxy units cGMP compliant time consuming: Sun Pharma  Money Control3 days ago Making Ranbaxy units cGMP complaint time consuming: Sun Pharma  Business Line3 days ago
[x]  
India Infoline

Indian cos looking to acquire US FDA approved API & formulation facilities to offset revenue losses

With rise in US FDA warning letters and import alerts to Indian pharma companies in recent years for not complying with good manufacturing practices, cash rich large and mid sized Indian companies are increasingly looking at the option of acquiring ...
 PharmaBiz1 week ago Sun Pharma slides on brokerage downgrade  Capital Market1 week ago Sun Pharma turns volatile after announcing Q1 results  Business Standard1 week ago Sun Pharma ends 0.7% down despite USFDA nod  India Infoline3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less